Biomed Central Ltd

SHERPA: Unknown

People

  1. Budhu
    Budhu
  2. Liu
    Liu
  3. Mangarin
    Mangarin
  4. Hirschhorn Cymerman
    Hirschhorn Cymerman
  5. Zhong
    Zhong
  6. Deng
    Deng
  7. Gupta
    Gupta
  8. Yang
    Yang
  9. Abdel-Wahab
    Abdel-Wahab
  10. Barker
    Barker

Groups

  1. Department of Medicine (55)
  2. Melanoma and Immunotherapeutics Service (55)
  3. Solid Tumor Oncology Division (55)
  4. GSK Faculty (48)
  5. Sloan Kettering Institute Postdocs (45)
  6. Hematology-Oncology Fellows (15)
  7. MSK Grad Students (11)
  8. Sloan Kettering Institute Faculty (10)
  9. GDMT, Medicine (9)
  10. Gynecologic Medicine Service (9)
Search Within
  1. "Taha Merghoub"
Formats
  1. Meeting Abstract (51)
  2. Journal Article (3)
  3. Guidelines (1)
Groups
  1. Department of Medicine (55)
  2. Melanoma and Immunotherapeutics Service (55)
  3. Solid Tumor Oncology Division (55)
  4. GSK Faculty (48)
  5. Sloan Kettering Institute Postdocs (45)
  6. Hematology-Oncology Fellows (15)

More Groups

People
  1. Taha Merghoub (55)
  2. Jedd Wolchok (47)
  3. Sadna Budhu (21)
  4. Roberta Zappasodi (20)
  5. Levi Mark Mangarin (11)
  6. Cailian Liu (10)

More People

Years
  1. 2022 (7)
  2. 2021 (8)
  3. 2020 (8)
  4. 2019 (2)
  5. 2018 (5)
  6. 2017 (11)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (55)

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Signal-regulatory protein alpha (SIRPĪ±) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Lag3 blockade in combination with GITR improves anti-tumor immune responses in a preclinical melanoma model
    Meeting Abstract

    Maniyar, R.; Zappasodi, R.; Elhanati, Y.; St Jean, S.; Carrasco, S.; Greenbaum, B.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Apr-246 induces an increase in tumor immunogenicity in a p53 independent manner
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Lu, C.; Budhu, S.; George, M.; Ouerfelli, O.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Development of optimized car T cells for therapy of glioblastoma
    Meeting Abstract

    Khan, J.; Cai, W.; Yang, Y.; Dong, L.; Hopland, K.; Yu, K. K. H.; Freeman, R.; Purdon, T.; Tabar, V.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Meeting Abstract

    Etxeberria, I.; Banks, L.; Chandran, S.; Correa, A.; Novak, B.; Fleischman, J.; Drilon, A.; Wolchok, J.; Merghoub, T.; Klebanoff, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy
    Meeting Abstract

    Verma, S.; Maniyar, R.; Ko, M.; Budhu, S.; Serganova, I.; Zappasodi, R.; Blasberg, R.; Merghoub, T.; Wolchok, J.; Mangarin, L.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save